Publications by authors named "Jon Chung"

Claim this Profile
N
Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial.
Joyce F Liu, Stéphanie Gaillard, Andrea E Wahner Hendrickson, Oladapo Yeku, Elisabeth Diver, Jon Chung

JCO Precis Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer.
Smruthy Sivakumar, Dexter X Jin, Hanna Tukachinsky, Karthikeyan Murugesan, Kimberly McGregor, Jon Chung

Nat Commun· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA.
Jessica K Lee, Mehlika Hazar-Rethinam, Brennan Decker, Ole Gjoerup, Russell W Madison, Jon H Chung

Clin Cancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
Andrea Necchi, Russell Madison, Sumanta K Pal, Jeffrey S Ross, Neeraj Agarwal, Jon H Chung

Eur Urol Focus· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genomic profiling of histologic subtypes of urethral carcinomas.
Joseph Jacob, Andrea Necchi, Petros Grivas, Michael Hughes, Thomas Sanford, Jon Chung

Urol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors.
Jonathan W Riess, Shaila Rahman, Waleed Kian, Claire Edgerly, Andreas M Heilmann, Jon H Chung

Transl Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.
Hanna Tukachinsky, Russell W Madison, Jon H Chung, Ole V Gjoerup, Eric A Severson

Clin Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma.
Gennady Bratslavsky, Stephanie Gleicher, Joseph M Jacob, Thomas H Sanford, Oleg Shapiro, Jon H Chung

Urol Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer.
Marco Bandini, Jeffrey S Ross, Daniele Raggi, Andrea Gallina, Maurizio Colecchia, Jon H Chung

J Natl Cancer Inst· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER Metastatic Breast Cancer.
Pingping Mao, Ofir Cohen, Kailey J Kowalski, Justin G Kusiel, Jorge E Buendia-Buendia, Jon Chung

Clin Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targetable gene fusions and aberrations in genitourinary oncology.
Filippo Pederzoli, Marco Bandini, Laura Marandino, Siraj M Ali, Russell Madison, Jon Chung

Nat Rev Urol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study.
Marco Bandini, Filippo Pederzoli, Russell Madison, Alberto Briganti, Jeffrey S Ross, Jon H Chung

Clin Genitourin Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling.
Russell Madison, Alexa B Schrock, Emily Castellanos, Jeffrey P Gregg, Jeremy Snider, Jon H Chung

Lung Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Squamous Transformation of Prostate Adenocarcinoma: A Report of Two Cases With Genomic Profiling.
Nazli Dizman, Meghan Salgia, Siraj M Ali, Huiqing Wu, Leonidas Arvanitis, Jon H Chung

Clin Genitourin Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study.
Andrea Necchi, Marco Bandini, Giuseppina Calareso, Daniele Raggi, Filippo Pederzoli, Jon H Chung

Eur Urol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions.
Russell W Madison, Sumati V Gupta, Yasir Y Elamin, Douglas I Lin, Sumanta K Pal, Jon H Chung

BJU Int· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies.
Andrea Necchi, Daniele Raggi, Andrea Gallina, Russell Madison, Maurizio Colecchia, Jon H Chung

Eur Urol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder.
Andrea Necchi, Russell Madison, Daniele Raggi, Joseph M Jacob, Gennady Bratslavsky, Jon H Chung

Eur Urol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-Cancer Analysis of and Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity.
Ethan S Sokol, Dean Pavlick, Hossein Khiabanian, Garrett M Frampton, Jeffrey S Ross, Jon H Chung

JCO Precis Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA.
Umut Disel, Russell Madison, Kumar Abhishek, Jon H Chung, Sally E Trabucco

Oncologist· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-Cancer Analysis of Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator Phenotype.
Ethan S Sokol, Dean Pavlick, Garrett M Frampton, Jeffrey S Ross, Vincent A Miller, Jon H Chung

Oncologist· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy.
Gerald Li, Dean Pavlick, Jon H Chung, Todd Bauer, Bradford A Tan

J Gastrointest Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors.
Andrea Necchi, Gennady Bratslavsky, Oleg Shapiro, Julia A Elvin, Jo-Anne Vergilio, Jon H Chung

Eur Urol Focus· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
Aatur D Singhi, Ben George, Joel R Greenbowe, Jon Chung, James Suh

Gastroenterology· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors.
Jon H Chung, Ninad Dewal, Ethan Sokol, Paul Mathew, Robert Whitehead

JCO Precis Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis